-
1
-
-
0037699954
-
The biology of VEGF and its receptors
-
Ferrara N, Gerber H-P, Le Couter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669-676.
-
(2003)
Nat Med.
, vol.9
, Issue.6
, pp. 669-676
-
-
Ferrara, N.1
Gerber, H.-P.2
Le Couter, J.3
-
2
-
-
4143136640
-
Vascular endothelial growth factor: Basic science and clinical progress
-
Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581-611.
-
(2004)
Endocr Rev.
, vol.25
, Issue.4
, pp. 581-611
-
-
Ferrara, N.1
-
3
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
Rosenfeld PJ, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-1431.
-
(2006)
N Engl J Med.
, vol.355
, Issue.14
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
-
4
-
-
33845191304
-
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema
-
Nguyen QD, et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol. 2006;142(6):961-969.
-
(2006)
Am J Ophthalmol.
, vol.142
, Issue.6
, pp. 961-969
-
-
Nguyen, Q.D.1
-
5
-
-
41149085598
-
Ranibizumab for macular edema due to retinal vein occlusions; implication of VEGF as a critical stimulator
-
Campochiaro PA, et al. Ranibizumab for macular edema due to retinal vein occlusions; implication of VEGF as a critical stimulator. Mol Ther. 2008;16(4):791-799.
-
(2008)
Mol Ther.
, vol.16
, Issue.4
, pp. 791-799
-
-
Campochiaro, P.A.1
-
6
-
-
77952891051
-
Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary endpoint results of a phase III study
-
Campochiaro PA, et al. Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary endpoint results of a phase III study. Ophthalmology. 2010;117(6):1102-1112.
-
(2010)
Ophthalmology
, vol.117
, Issue.6
, pp. 1102-1112
-
-
Campochiaro, P.A.1
-
7
-
-
77952889477
-
Efficacy and safety of ranibizumab in the treatment of macular edema secondary to central retinal vein occlusion:6-month results of the phase III CRUISE study
-
Brown DM, et al. Efficacy and safety of ranibizumab in the treatment of macular edema secondary to central retinal vein occlusion:6-month results of the phase III CRUISE study. Ophthalmology. 2010;117(6):1124-1133.
-
(2010)
Ophthalmology
, vol.117
, Issue.6
, pp. 1124-1133
-
-
Brown, D.M.1
-
8
-
-
84863401792
-
Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE
-
Nguyen QD, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789-801.
-
(2012)
Ophthalmology
, vol.119
, Issue.4
, pp. 789-801
-
-
Nguyen, Q.D.1
-
9
-
-
84862817252
-
Ranibizumab for macular edema due to retinal vein occlusions: Long term follow-up in the HORIZON trial
-
Heier JS, et al. Ranibizumab for macular edema due to retinal vein occlusions: long term follow-up in the HORIZON trial. Ophthalmology. 2012;119(4):802-809.
-
(2012)
Ophthalmology
, vol.119
, Issue.4
, pp. 802-809
-
-
Heier, J.S.1
-
10
-
-
78049293726
-
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
-
Nguyen QD, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology. 2010;117(11):2146-2151.
-
(2010)
Ophthalmology
, vol.117
, Issue.11
, pp. 2146-2151
-
-
Nguyen, Q.D.1
-
11
-
-
84891631064
-
Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: The RETAIN study
-
Campochiaro PA, et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014;121(1):209-219.
-
(2014)
Ophthalmology
, vol.121
, Issue.1
, pp. 209-219
-
-
Campochiaro, P.A.1
-
12
-
-
15144358851
-
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
-
Maisonpierre PC, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277(5322):55-60.
-
(1997)
Science
, vol.277
, Issue.5322
, pp. 55-60
-
-
Maisonpierre, P.C.1
-
13
-
-
0033882191
-
Angiopoietin 2 expression in the retina: Upregulation during physiologic and pathologic neovascularization
-
Hackett SF, et al. Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol. 2000;184(3):275-284.
-
(2000)
J Cell Physiol.
, vol.184
, Issue.3
, pp. 275-284
-
-
Hackett, S.F.1
-
14
-
-
0036306063
-
Angiopoietin-2 plays an important role in retinal angiogenesis
-
Hackett SF, Wiegand SJ, Yancopoulos G, Campochiaro P. Angiopoietin-2 plays an important role in retinal angiogenesis. J Cell Physiol. 2002;192(2):182-187.
-
(2002)
J Cell Physiol.
, vol.192
, Issue.2
, pp. 182-187
-
-
Hackett, S.F.1
Wiegand, S.J.2
Yancopoulos, G.3
Campochiaro, P.4
-
15
-
-
18644382318
-
Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1
-
Gale NW, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell. 2002;3(3):411-423.
-
(2002)
Dev Cell.
, vol.3
, Issue.3
, pp. 411-423
-
-
Gale, N.W.1
-
16
-
-
2342592123
-
Intraocular gutless adenoviral vectored VEGF stimulates anterior segment but not retinal neovascularization
-
Oshima Y, et al. Intraocular gutless adenoviral vectored VEGF stimulates anterior segment but not retinal neovascularization. J Cell Physiol. 2004;199(3):399-411.
-
(2004)
J Cell Physiol.
, vol.199
, Issue.3
, pp. 399-411
-
-
Oshima, Y.1
-
17
-
-
20444437236
-
Different effects of angiopoietin 2 in different vascular beds in the eye; new vessels are most sensitive
-
Oshima Y, et al. Different effects of angiopoietin 2 in different vascular beds in the eye; new vessels are most sensitive. FASEB J. 2005;19(8):963-965.
-
(2005)
FASEB J.
, vol.19
, Issue.8
, pp. 963-965
-
-
Oshima, Y.1
-
18
-
-
0030480322
-
Requisite role of Angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis
-
Suri C, et al. Requisite role of Angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell. 1996;87(7):1171-1180.
-
(1996)
Cell
, vol.87
, Issue.7
, pp. 1171-1180
-
-
Suri, C.1
-
19
-
-
2642557374
-
Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier
-
Nambu H, et al. Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier. Gene Ther. 2004;11(10):865-873.
-
(2004)
Gene Ther.
, vol.11
, Issue.10
, pp. 865-873
-
-
Nambu, H.1
-
20
-
-
20144374351
-
Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization
-
Nambu H, Umeda N, Kachi S, Oshima Y, Nambu R, Campochiaro PA. Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization. J Cell Physiol. 2005;204(1):227-235.
-
(2005)
J Cell Physiol.
, vol.204
, Issue.1
, pp. 227-235
-
-
Nambu, H.1
Umeda, N.2
Kachi, S.3
Oshima, Y.4
Nambu, R.5
Campochiaro, P.A.6
-
21
-
-
0025146562
-
Structural diversity and evolution of human receptorlike protein tyrosine phosphatases
-
Krueger NX, Streuli M, Saito H. Structural diversity and evolution of human receptorlike protein tyrosine phosphatases. EMBO J. 1990;9(10):3241-3252.
-
(1990)
EMBO J.
, vol.9
, Issue.10
, pp. 3241-3252
-
-
Krueger, N.X.1
Streuli, M.2
Saito, H.3
-
22
-
-
0033592739
-
Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2
-
Fachinger G, Deutsch U, Risau W. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene. 1999;18(43):5948-5953.
-
(1999)
Oncogene.
, vol.18
, Issue.43
, pp. 5948-5953
-
-
Fachinger, G.1
Deutsch, U.2
Risau, W.3
-
23
-
-
33745107561
-
Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development
-
Baumer S, et al. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood. 2006;107(12):4754-4762.
-
(2006)
Blood
, vol.107
, Issue.12
, pp. 4754-4762
-
-
Baumer, S.1
-
24
-
-
33847636046
-
Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis
-
Dominguez MG, et al. Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci U S A. 2007;104(9):3243-3248.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, Issue.9
, pp. 3243-3248
-
-
Dominguez, M.G.1
-
25
-
-
61449145430
-
Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells
-
Yacyshyn OK, Lai P F H, Forse K, Teichert-Kuliszewska K, Jurasz P, Stewart DJ. Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells. Angiogenesis. 2009;12(1):25-33.
-
(2009)
Angiogenesis.
, vol.12
, Issue.1
, pp. 25-33
-
-
Yacyshyn, O.K.1
Lai, P.F.H.2
Forse, K.3
Teichert-Kuliszewska, K.4
Jurasz, P.5
Stewart, D.J.6
-
26
-
-
66149094158
-
VE-PTP control blood vessel development by balancing Tie-2 activity
-
Winderlich M, et al. VE-PTP control blood vessel development by balancing Tie-2 activity. J Cell Biol. 2009;185(4):657-671.
-
(2009)
J Cell Biol.
, vol.185
, Issue.4
, pp. 657-671
-
-
Winderlich, M.1
-
27
-
-
0027982899
-
Oxygen-induced retinopathy in the mouse
-
Smith L E H, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35(1):101-111.
-
(1994)
Invest Ophthalmol Vis Sci.
, vol.35
, Issue.1
, pp. 101-111
-
-
Smith, L.E.H.1
-
28
-
-
0034791933
-
Retinal angiomatous proliferation in age-related macular degeneration
-
Yannuzzi LA, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21(5):416-434.
-
(2001)
Retina.
, vol.21
, Issue.5
, pp. 416-434
-
-
Yannuzzi, L.A.1
-
29
-
-
0031768434
-
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model
-
Tobe T, et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol. 1998;153(5):1641-1646.
-
(1998)
Am J Pathol.
, vol.153
, Issue.5
, pp. 1641-1646
-
-
Tobe, T.1
-
30
-
-
0030844479
-
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization
-
Okamoto N, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol. 1997;151(1):281-291.
-
(1997)
Am J Pathol.
, vol.151
, Issue.1
, pp. 281-291
-
-
Okamoto, N.1
-
31
-
-
0031975156
-
Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors
-
Tobe T, et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci. 1998;39(1):180-188.
-
(1998)
Invest Ophthalmol Vis Sci.
, vol.39
, Issue.1
, pp. 180-188
-
-
Tobe, T.1
-
32
-
-
0037401890
-
VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier
-
Saishin Y, et al. VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol. 2003;195(2):241-248.
-
(2003)
J Cell Physiol.
, vol.195
, Issue.2
, pp. 241-248
-
-
Saishin, Y.1
-
33
-
-
79957990661
-
The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as needed after 12-week fixed dosing
-
Heier JS, et al. The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as needed after 12-week fixed dosing. Ophthalmology. 2011;118(6):1098-1106.
-
(2011)
Ophthalmology
, vol.118
, Issue.6
, pp. 1098-1106
-
-
Heier, J.S.1
-
34
-
-
32044449378
-
1, 2, 3, 4-Tetrahydroisoquinolinyl sulfamic acids as phsophatase PTP1B inhibitors
-
Klopfenstein SR, et al. 1, 2, 3, 4-Tetrahydroisoquinolinyl sulfamic acids as phsophatase PTP1B inhibitors. Bioorg Med Chem Lett. 2006;16(6):1574-1578.
-
(2006)
Bioorg Med Chem Lett.
, vol.16
, Issue.6
, pp. 1574-1578
-
-
Klopfenstein, S.R.1
-
35
-
-
33845479013
-
Engineering the catalytic domain of human protein tyrosine phosphatase β for structure-based drug discovery
-
Evdokimov AG, et al. Engineering the catalytic domain of human protein tyrosine phosphatase β for structure-based drug discovery. Acta Crystallogr D Biol Crystallogr. 2006;62(pt 12):1435-1445.
-
(2006)
Acta Crystallogr D Biol Crystallogr.
, vol.62
, pp. 1435-1445
-
-
Evdokimov, A.G.1
-
36
-
-
33745953734
-
Design and synthesis of potent, non-peptidic inhibiors of HPTPβ
-
Amarasinghe K K D, et al. Design and synthesis of potent, non-peptidic inhibiors of HPTPβ. Bioorg Med Chem Lett. 2006;16(16):4252-4256.
-
(2006)
Bioorg Med Chem Lett.
, vol.16
, Issue.16
, pp. 4252-4256
-
-
Amarasinghe, K.K.D.1
-
37
-
-
0033601357
-
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
-
Thurston G, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286(5449):2511-2515.
-
(1999)
Science
, vol.286
, Issue.5449
, pp. 2511-2515
-
-
Thurston, G.1
-
38
-
-
0024551654
-
Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics
-
Vinores SA, Gadegbeku C, Campochiaro PA, Green WR. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol. 1989;134(2):231-235.
-
(1989)
Am J Pathol.
, vol.134
, Issue.2
, pp. 231-235
-
-
Vinores, S.A.1
Gadegbeku, C.2
Campochiaro, P.A.3
Green, W.R.4
-
39
-
-
0025301320
-
Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin
-
Vinores SA, Campochiaro PA, Lee A, McGehee R, Gadegbeku C, Green WR. Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin. Lab Invest. 1990;62(6):742-750.
-
(1990)
Lab Invest.
, vol.62
, Issue.6
, pp. 742-750
-
-
Vinores, S.A.1
Campochiaro, P.A.2
Lee, A.3
McGehee, R.4
Gadegbeku, C.5
Green, W.R.6
-
40
-
-
0037401530
-
Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier
-
Saishin Y, Saishin Y, Takahashi K, Melia M, Vinores SA, Campochiaro PA. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier. J Cell Physiol. 2003;195(2):210-219.
-
(2003)
J Cell Physiol.
, vol.195
, Issue.2
, pp. 210-219
-
-
Saishin, Y.1
Saishin, Y.2
Takahashi, K.3
Melia, M.4
Vinores, S.A.5
Campochiaro, P.A.6
-
41
-
-
0036168483
-
Inducible expression of vascular endothelial growth factor in photoreceptors of adult mice causes severe proliferative retinopathy and retinal detachment
-
Ohno-Matsui K, et al. Inducible expression of vascular endothelial growth factor in photoreceptors of adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol. 2002;160(2):711-719.
-
(2002)
Am J Pathol.
, vol.160
, Issue.2
, pp. 711-719
-
-
Ohno-Matsui, K.1
-
42
-
-
2342440066
-
Functional significance of Tie2 signaling in the adult vasculature
-
Peters KG, et al. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res. 2004;59:51-71.
-
(2004)
Recent Prog Horm Res.
, vol.59
, pp. 51-71
-
-
Peters, K.G.1
-
43
-
-
60749096085
-
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
-
Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009;10(3):165-177.
-
(2009)
Nat Rev Mol Cell Biol.
, vol.10
, Issue.3
, pp. 165-177
-
-
Augustin, H.G.1
Koh, G.Y.2
Thurston, G.3
Alitalo, K.4
-
44
-
-
0030764063
-
Tie2 expression and phosphorylation in agiogenic and quiescent adult tissues
-
Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in agiogenic and quiescent adult tissues. Circ Res. 1997;81(4):567-574.
-
(1997)
Circ Res.
, vol.81
, Issue.4
, pp. 567-574
-
-
Wong, A.L.1
Haroon, Z.A.2
Werner, S.3
Dewhirst, M.W.4
Greenberg, C.S.5
Peters, K.G.6
-
45
-
-
0344874751
-
Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1
-
Kelly BD, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res. 2003;93(11):1074-1081.
-
(2003)
Circ Res.
, vol.93
, Issue.11
, pp. 1074-1081
-
-
Kelly, B.D.1
-
46
-
-
0037143737
-
Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
-
Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002;99(17):11205-11210.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.17
, pp. 11205-11210
-
-
Lobov, I.B.1
Brooks, P.C.2
Lang, R.A.3
-
47
-
-
2342526664
-
Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor
-
Oshima Y, et al. Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor. J Cell Physiol. 2004;199(3):412-417.
-
(2004)
J Cell Physiol.
, vol.199
, Issue.3
, pp. 412-417
-
-
Oshima, Y.1
-
48
-
-
0033168876
-
Extracellular matrix-integrin binding modulates secretion of angiogenic growth factors by retinal pigmented epithelial cells
-
Mousa SA, Lorelli W, Campochiaro PA. Extracellular matrix-integrin binding modulates secretion of angiogenic growth factors by retinal pigmented epithelial cells. J Cell Biochem. 1999;74(1):135-143.
-
(1999)
J Cell Biochem.
, vol.74
, Issue.1
, pp. 135-143
-
-
Mousa, S.A.1
Lorelli, W.2
Campochiaro, P.A.3
-
49
-
-
31944433624
-
Implication of the hypoxia response element of the VEGF promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development
-
Vinores SA, et al. Implication of the hypoxia response element of the VEGF promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol. 2006;206(3):749-758.
-
(2006)
J Cell Physiol.
, vol.206
, Issue.3
, pp. 749-758
-
-
Vinores, S.A.1
-
50
-
-
64649084437
-
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
-
Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol. 2009;29(8):2011-2022.
-
(2009)
Mol Cell Biol.
, vol.29
, Issue.8
, pp. 2011-2022
-
-
Yuan, H.T.1
Khankin, E.V.2
Karumanchi, S.A.3
Parikh, S.M.4
-
51
-
-
9644279384
-
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: Effects of laser photocoagulation and angiotensin receptor blockade
-
Lip PL, et al. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol. 2004;88(12):1543-1546.
-
(2004)
Br J Ophthalmol.
, vol.88
, Issue.12
, pp. 1543-1546
-
-
Lip, P.L.1
-
52
-
-
69249213967
-
Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor
-
Miki K, Miki A, Matsuoka M, Muramatsu D, Hackett SF, Campochiaro PA. Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor. Ophthalmology. 2009;116(9):1748-1754.
-
(2009)
Ophthalmology
, vol.116
, Issue.9
, pp. 1748-1754
-
-
Miki, K.1
Miki, A.2
Matsuoka, M.3
Muramatsu, D.4
Hackett, S.F.5
Campochiaro, P.A.6
-
53
-
-
77952524928
-
Alterations in the intracellular cytokine milieu after intravitreal bevacizumab
-
Forooghian F, Kertes PJ, Eng KT, Agron E, Chew EY. Alterations in the intracellular cytokine milieu after intravitreal bevacizumab. Invest Ophthalmol Vis Sci. 2010;51(5):2388-2392.
-
(2010)
Invest Ophthalmol Vis Sci.
, vol.51
, Issue.5
, pp. 2388-2392
-
-
Forooghian, F.1
Kertes, P.J.2
Eng, K.T.3
Agron, E.4
Chew, E.Y.5
-
54
-
-
58149291905
-
VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF
-
Nottebaum AF, et al. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med. 2008;205(12):2929-2945.
-
(2008)
J Exp Med.
, vol.205
, Issue.12
, pp. 2929-2945
-
-
Nottebaum, A.F.1
-
55
-
-
84855493801
-
Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo
-
Broermann A, et al. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. J Exp Med. 2011;208(12):2393-2401.
-
(2011)
J Exp Med.
, vol.208
, Issue.12
, pp. 2393-2401
-
-
Broermann, A.1
-
56
-
-
84883174690
-
Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression
-
Goel S, et al. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. J Natl Cancer Inst. 2013;105(16):1188-1201.
-
(2013)
J Natl Cancer Inst.
, vol.105
, Issue.16
, pp. 1188-1201
-
-
Goel, S.1
-
57
-
-
84860261133
-
Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice
-
McClung JM, et al. Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice. Am J Pathol. 2012;180(5):2156-2169.
-
(2012)
Am J Pathol.
, vol.180
, Issue.5
, pp. 2156-2169
-
-
McClung, J.M.1
-
58
-
-
0037200045
-
Deletion of the carboxyl terminus of Tie2 enhances kinase activity, signaling, and function. Evidence for an autoinhibitory mechanism
-
Niu XL, Peters KG, Kontos CD. Deletion of the carboxyl terminus of Tie2 enhances kinase activity, signaling, and function. Evidence for an autoinhibitory mechanism. J Biol Chem. 2002;277(35):31768-31773.
-
(2002)
J Biol Chem.
, vol.277
, Issue.35
, pp. 31768-31773
-
-
Niu, X.L.1
Peters, K.G.2
Kontos, C.D.3
-
59
-
-
0028910237
-
Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA
-
Fontijn R, et al. Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Exp. Cell Res. 1995;216(1):199-201.
-
(1995)
Exp. Cell Res.
, vol.216
, Issue.1
, pp. 199-201
-
-
Fontijn, R.1
-
60
-
-
77953515701
-
Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization
-
Yoshida T, Zhang H, Iwase T, Shen J, Semenza GL, Campochiaro PA. Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization. FASEB J. 2010;24(6):1759-1767.
-
(2010)
FASEB J.
, vol.24
, Issue.6
, pp. 1759-1767
-
-
Yoshida, T.1
Zhang, H.2
Iwase, T.3
Shen, J.4
Semenza, G.L.5
Campochiaro, P.A.6
-
61
-
-
80052278961
-
Vascular cell adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress
-
Dong A, Shen J, Zeng M, Campochiaro PA. Vascular cell adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress. Proc Natl Acad Sci U S A. 2011;108(35):14614-14619.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.35
, pp. 14614-14619
-
-
Dong, A.1
Shen, J.2
Zeng, M.3
Campochiaro, P.A.4
-
62
-
-
39149139617
-
Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling
-
Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity. 2008;28(2):183-196.
-
(2008)
Immunity
, vol.28
, Issue.2
, pp. 183-196
-
-
Zhu, J.W.1
Brdicka, T.2
Katsumoto, T.R.3
Lin, J.4
Weiss, A.5
-
63
-
-
0030979054
-
Tie2 receptor expression and phosphorylation in cultured cells and mouse tissues
-
Koblizek TI, Runting AS, Stacker SA, Wilks AF, Risau W, Deutsch U. Tie2 receptor expression and phosphorylation in cultured cells and mouse tissues. Eur J Biochem. 1997;244(3):774-779.
-
(1997)
Eur J Biochem.
, vol.244
, Issue.3
, pp. 774-779
-
-
Koblizek, T.I.1
Runting, A.S.2
Stacker, S.A.3
Wilks, A.F.4
Risau, W.5
Deutsch, U.6
-
64
-
-
77957738254
-
Agents that bind annexin A2 suppress ocular neovascularization
-
Lima E Silva R, et al. Agents that bind annexin A2 suppress ocular neovascularization. J Cell Physiol. 2010;225(3):855-864.
-
(2010)
J Cell Physiol.
, vol.225
, Issue.3
, pp. 855-864
-
-
Silva, L.E.R.1
|